Abstract
It is well known that the hemoprotein cytochrome P-450 (EC 1.14.14.1) is the key enzyme for the biotransformation of xenobiotics in the mammalian organism (Rein 1973; Schuster 1977; Ullrich 1977). Depending on the chemical nature of the xenobiotic, either a detoxification or an activation is effected by this enzyme (Coon and Vatsis 1978). The enzymatic reaction is connected with a splitting of molecular oxygen and the insertion of one atom oxygen into the substrate, thus converting a hydrophobic compound into a more polar product. On the one hand the excretion of such a tranformed foreign compound is facilitated. On the other hand, however, the insertion of a reactive group into the molecule induces the possibility of covalent binding to proteins and nucleic acids resulting in toxic substances, even in the formation of mutagens and carcinogens. This biological importance of cytochrome P-450 requires the knowledge of the molecular mechanism in order to control activation and inhibition at acute and chronic intoxications and moreover for the extracorporal use of the enzyme (Cohen et al. 1977). Cytochrome P-450 is localized in the membrane of the endoplasmatic reticulum or in the inner membrane of mitochondria. Two thirds of the total content in the organism is concentrated in the liver, but it is also present in the cells of the intestinal wall, skin, kidney and in brochiolar (Clara) cells of the lung. The activation of molecular oxygen catalyzed by the enzyme requires electrons which are transferred from NADPH via cytochrome P-450 reductase (EC 1.6.4.2) to the terminal oxidase. The interaction between both functionally linked proteins is mediated by phospholipids (Estabrook and Werringloer 1979).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beetlestone J, George P (1961) Biochemistry 3: 707
Björkhem I (1977) Pharmacol Ther A 1: 327
Blanck J, Smettan G (1978) Pharmazie 33: 321
Blanck J, Graf W, Scheler W (1961) Acta Biol Med Germ 7: 323
Champion P, Munck E, Debrunner P, Moss T, Lipscomb J, Gunsalus I (1975) Biochim Biophys Acta 376: 579
Chevion M, Peisach J, Blumberg WE (1977) J Biol Chem 252: 3637
Cohen W, Baricos WH, Kastl PR, Chambers RP (1977) In: Ming Swi Chang T (ed) Biomedical applications of immobilized enzymes and proteins. Plenum Press, New York London
Coon M J, Vatsis KP (1978) Poly cyclic hydrocarbons and cancer, vol I. Academic Press, London New York, p 336
Coon MJ, White RE, Nordblom GD, Ballou DP, Guengerich FP (1977) Croat Chem Acta 49: 163
Dawson J, Trudell J, Linder R, Barth G, Bunnenberg E, Djerassi C (1978) Biochemistry 17: 33
Estabrook RW, Werringloer J (1979) In: Estabrook RW, Lindenlaub E (eds) The induction of drug metabolism. Schattauer, Stuttgart New York, p 187
Guengerich FB, Ballou DP, Coon MJ (1975) J Biol Chem 250: 7405
Haugen DA, van der Hoeven TA, Coon MJ (1975) J Biol Chem 250: 3567
Hoeven TA van der, Haugen DA, Coon MJ (1974) Biochem Biophys Res Commun 60: 569
Iizuka T, Kotani M (1969) Biochim Biophys Acta 181: 275
Ikegami A (1977) Biophys Chem 6: 131
Kadish KM, Davis DG (1973) Ann NY Acad Sci 206: 495
König E, Ritter G (1974) In: Gruverman IJ, Seidel CW, Dieterly DK (eds) Mössbauer effect methodology, vol IX. Plenum Press, New York, p 3
Kotani M (1969) Ann NY Acad Sei 158: 20
LaMar G, Walker F (1972) J Am Chem Soc 94: 8607
Matsubara T, Baron J, Perterson LL, Peterson JA (1976) Arch Biochem Biophys 172: 463
Misselwitz R, Jänig G-R, Rein H, Buder E, Zirwer D, Ruckpaul K (1975) Acta Biol Med Germ 34: 1755
Misselwitz R, Jänig G-R, Rein H, Buder E, Zirwer D, Ruckpaul K (1976) Acta Biol Med Germ 35: K 19
Otsuka J (1970) Biochim Biophys Acta 314: 233
Rein H (1973) Wissensch Fortschr 23: 502
Rein H, Ristau O (1978) Pharmazie 33: 325
Rein H, Jänig G-R, Winkler W, Ruckpaul K (1976) Acta Biol Med Germ 35:K 41
Rein H, Ristau O, Friedrich J, Jänig G-R, Ruckpaul K (1977) FEBS Lett 75: 19
Rein H, Ristau O, Misselwitz R, Buder E, Ruckpaul K (1979) Acta Biol Med Germ 38: 187
Ristau O, Rein H, Jänig G-R, Ruckpaul K (1978) Biochim Biophys Acta 536: 226
Ristau O, Rein H, Greschner S, Jänig G-R, Ruckpaul K (1979) Acta Biol Med Germ 38: 177
Ruckpaul K, Rein H, Ballou DP. Coon MJ (1980) Proceedings of the 4th meeting on microsomes, drug oxidations and chemical carcinogenesis. Academic Press, London New York, p 37
Scheler W, Schoffa G, Jung F (1957) Biochem Z 329: 232
Schenkman JB, Remmer R, Estabrook RW (1967) Mol Pharmacol 3: 113
Schuster I (1977) In: Hahn FE (ed) Progress in molecular and submolecular biology, vol V. Springer, Berlin Heidelberg New York, p 31
Sligar SG (1976) Biochemistry 15: 5399
Sligar SG, Cinti DL,Gibson GG, Schenkman JB (1979) Biochem Biophys Res Commun 90: 925
Ullrich V (1977) Arzneimittelforschung 27 (II): 9b, 1821
Ullrich V, Nastainczk W, Ruf HH (1975) Biochem Soc Trans 3: 803
Ullrich V, Sakurai H, Ruf HH (1979) Acta Biol Med Germ 38: 287
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rein, H., Ristau, O., Ruckpaul, K. (1981). Molecular Mechanism of the Xenobiotica Metabolizing Enzyme Cytochrome P-450. In: Gut, I., Cikrt, M., Plaa, G.L. (eds) Industrial and Environmental Xenobiotics. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68195-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-68195-0_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68197-4
Online ISBN: 978-3-642-68195-0
eBook Packages: Springer Book Archive